Treatment of Male Pattern Baldness With Botulinum Toxin

Male Pattern Baldness Clinical Trial

Official title:

A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00965640
• Other study ID #: MPB-2002-01
• Secondary ID: HPB 081023
• Status: Completed
• Phase: Phase 2
• First received: August 24, 2009
• Last updated: August 24, 2009
• Start date: December 2002
• Est. completion date: June 2004

Study information

• Verified date: August 2009
• Source: The Crown Institute
• Contact: n/a
• Is FDA regulated: No
• Health authority: Canada: Health Canada
• Study type: Interventional

Clinical Trial Summary

This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: June 2004
• Est. primary completion date: June 2004
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Male
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• Male pattern baldness

• Norwood II-VI

Exclusion Criteria:

• Treatment with Botulinum toxins or other hair growth interventions with past year

Study Design

Primary Purpose: Screening

Related Conditions & MeSH terms

• Alopecia
• Alopecia Areata
• Male Pattern Baldness

Intervention

Drug:
• Botulinum Toxin - A injections

Locations

Country	Name	City	State
Canada	Crown Institute	Pickering	Ontario

Sponsors (1)

Lead Sponsor	Collaborator
The Crown Institute

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hair Growth		1 year	Yes
Secondary	Hair Loss		1 year	Yes